263 related articles for article (PubMed ID: 33645319)
1. Disparate roles of retinoid acid signaling molecules in kidney disease.
Chen A; Liu Y; Lu Y; Lee K; He JC
Am J Physiol Renal Physiol; 2021 May; 320(5):F683-F692. PubMed ID: 33645319
[TBL] [Abstract][Full Text] [Related]
2. Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.
Chen A; Feng Y; Lai H; Ju W; Li Z; Li Y; Wang A; Hong Q; Zhong F; Wei C; Fu J; Guan T; Liu B; Kretzler M; Lee K; He JC
J Clin Invest; 2020 Oct; 130(10):5523-5535. PubMed ID: 32634130
[TBL] [Abstract][Full Text] [Related]
3. Novel retinoic acid receptor alpha agonists for treatment of kidney disease.
Zhong Y; Wu Y; Liu R; Li Z; Chen Y; Evans T; Chuang P; Das B; He JC
PLoS One; 2011; 6(11):e27945. PubMed ID: 22125642
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor α.
Dai Y; Chen A; Liu R; Gu L; Sharma S; Cai W; Salem F; Salant DJ; Pippin JW; Shankland SJ; Moeller MJ; Ghyselinck NB; Ding X; Chuang PY; Lee K; He JC
Kidney Int; 2017 Dec; 92(6):1444-1457. PubMed ID: 28756872
[TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway.
Elsayed AM; Abdelghany TM; Akool el-S; Abdel-Aziz AA; Abdel-Bakky MS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):327-37. PubMed ID: 26659823
[TBL] [Abstract][Full Text] [Related]
6. Suppression of nephrin expression by TNF-alpha via interfering with the cAMP-retinoic acid receptor pathway.
Saito Y; Okamura M; Nakajima S; Hayakawa K; Huang T; Yao J; Kitamura M
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1436-44. PubMed ID: 20237236
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway.
He JC; Lu TC; Fleet M; Sunamoto M; Husain M; Fang W; Neves S; Chen Y; Shankland S; Iyengar R; Klotman PE
J Am Soc Nephrol; 2007 Jan; 18(1):93-102. PubMed ID: 17182884
[TBL] [Abstract][Full Text] [Related]
8. Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor.
Masiá S; Alvarez S; de Lera AR; Barettino D
Mol Endocrinol; 2007 Oct; 21(10):2391-402. PubMed ID: 17595318
[TBL] [Abstract][Full Text] [Related]
9. Role of the retinoic acid receptor-α in HIV-associated nephropathy.
Ratnam KK; Feng X; Chuang PY; Verma V; Lu TC; Wang J; Jin Y; Farias EF; Napoli JL; Chen N; Kaufman L; Takano T; D'Agati VD; Klotman PE; He JC
Kidney Int; 2011 Mar; 79(6):624-634. PubMed ID: 21150871
[TBL] [Abstract][Full Text] [Related]
10. The yin and yang of retinoic acid signaling in kidney diseases.
Wei Q; Dong Z
J Clin Invest; 2020 Oct; 130(10):5124-5126. PubMed ID: 32925167
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid receptor responder1 promotes development of glomerular diseases via the Nuclear Factor-κB signaling pathway.
Möller-Hackbarth K; Dabaghie D; Charrin E; Zambrano S; Genové G; Li X; Wernerson A; Lal M; Patrakka J
Kidney Int; 2021 Oct; 100(4):809-823. PubMed ID: 34147551
[TBL] [Abstract][Full Text] [Related]
12. Vitamin A and retinoid signaling in the kidneys.
DiKun KM; Gudas LJ
Pharmacol Ther; 2023 Aug; 248():108481. PubMed ID: 37331524
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid-induced blr1 expression requires RARalpha, RXR, and MAPK activation and uses ERK2 but not JNK/SAPK to accelerate cell differentiation.
Battle TE; Roberson MS; Zhang T; Varvayanis S; Yen A
Eur J Cell Biol; 2001 Jan; 80(1):59-67. PubMed ID: 11211936
[TBL] [Abstract][Full Text] [Related]
14. Autocrine and paracrine effects of a novel podocyte gene, RARRES1.
Chen A; Lee K; He JC
Kidney Int; 2021 Oct; 100(4):745-747. PubMed ID: 34556297
[TBL] [Abstract][Full Text] [Related]
15. Podocyte-derived soluble RARRES1 drives kidney disease progression through direct podocyte and proximal tubular injury.
Feng Y; Sun Z; Fu J; Zhong F; Zhang W; Wei C; Chen A; Liu BC; He JC; Lee K
Kidney Int; 2024 Apr; ():. PubMed ID: 38697478
[TBL] [Abstract][Full Text] [Related]
16. A novel retinoic acid receptor (RAR)-selective antagonist inhibits differentiation and apoptosis of HL-60 cells: implications of RARalpha-mediated signals in myeloid leukemic cells.
Ueno H; Kizaki M; Matsushita H; Muto A; Yamato K; Nishihara T; Hida T; Yoshimura H; Koeffler HP; Ikeda Y
Leuk Res; 1998 Jun; 22(6):517-25. PubMed ID: 9678718
[TBL] [Abstract][Full Text] [Related]
17. Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation.
Johnson BS; Chandraratna RA; Heyman RA; Allegretto EA; Mueller L; Collins SJ
Mol Cell Biol; 1999 May; 19(5):3372-82. PubMed ID: 10207061
[TBL] [Abstract][Full Text] [Related]
18. The role of retinoic acid receptors in the signal pathway of all-trans retinoic acid-induced differentiation in adriamycin-induced podocyte injury.
Chen XP; Lei FY; Qin YH; Zhou TB; Jiang L; Zhao YJ; Huang WF; Peng QL
J Recept Signal Transduct Res; 2014 Dec; 34(6):484-92. PubMed ID: 24846581
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis.
Hatoum A; El-Sabban ME; Khoury J; Yuspa SH; Darwiche N
Carcinogenesis; 2001 Dec; 22(12):1955-63. PubMed ID: 11751425
[TBL] [Abstract][Full Text] [Related]
20. Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation.
Mallipattu SK; Liu R; Zheng F; Narla G; Ma'ayan A; Dikman S; Jain MK; Saleem M; D'Agati V; Klotman P; Chuang PY; He JC
J Biol Chem; 2012 Jun; 287(23):19122-35. PubMed ID: 22493483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
